As the presence of tumor cells circulating in the blood is associated with systemic disease
and shortened survival, the establishment of a method to detect circulating tumor cells …

Solid cancers are a leading cause of death worldwide, primarily due to the failure of effective
clinical detection and treatment of metastatic disease in distant sites. There is growing …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Circulating tumor cells (CTC) can be detected in the peripheral blood of patients with a
variety of solid cancers. Because of their very low frequency, these tumor cells are not easily …

Recent molecular and clinical studies have shown that invasion may occur very early in
tumor development, thus emphasizing the potential importance of specific and sensitive …

Circulating Tumour Cells (CTCs) can be released from the primary tumour into the
bloodstream and may colonize distant organs giving rise to metastasis. The presence of …

Circulating tumor cells (CTCs) are cells derived from the primary sites of tumor patients into
peripheral blood and serve as seeds that initiate tumor metastasis to distant sites. As a …